(CERT) – StreetInsider.com Reports
-
KeyBanc Upgrades Certara Inc. (CERT) to Overweight
-
JMP Securities Starts Certara Inc. (CERT) at Market Perform, 'We like CERT's competitive positioning and reputation '
-
Certara Inc. (CERT) PT Raised to $20 at UBS
-
Certara Inc. (CERT) PT Raised to $15.50 at Jefferies
-
Leerink Partners Starts Certara Inc. (CERT) at Market Perform
-
Certara Inc. (CERT) PT Raised to $18 at Barclays
-
UBS Starts Certara Inc. (CERT) at Neutral
-
KeyBanc Starts Certara Inc. (CERT) at Sector Weight
-
Certara, Inc. (CERT) Introduces Simcyp Biopharmaceutics Software
-
Certara Inc. (CERT) PT Lowered to $16 at Baird
-
Certara, Inc. (CERT) Reports In-Line Q3 EPS
-
Certara Inc. (CERT) PT Lowered to $20 at BofA Securities
-
Certara, Inc. (CERT) Awarded Two New Grants from US FDA
-
Certara Inc. (CERT) PT Lowered to $19 at Berenberg
-
Jefferies Downgrades Certara Inc. (CERT) to Hold, 'Rebound Unlikely; Challenging Macro'
-
Certara Inc. (CERT) PT Lowered to $24 at BofA Securities
-
Certara Inc. (CERT) PT Lowered to $16 at Barclays
-
Certara Inc. (CERT) PT Lowered to $21 at Morgan Stanley
-
William Blair Downgrades Certara Inc. (CERT) to Market Perform, 'Alarming Decline in Services Bookings'
-
Certara Inc. (CERT) PT Lowered to $17 at Baird
-
Certara Inc. (CERT) PT Lowered to $21 at Credit Suisse
-
Certara, Inc. (CERT) Misses Q2 EPS by 1c
-
Certara Inc. (CERT) PT Lowered to $24 at Berenberg
-
Certara Inc. (CERT) PT Raised to $22 at Morgan Stanley
-
Certara Inc. (CERT) PT Lowered to $19 at Baird
-
Certara Inc. (CERT) PT Lowered to $18 at Barclays
-
Certara Inc. (CERT) PT Raised to $24.50 at Jefferies
-
Certara, Inc. (CERT) Reports In-Line Q1 EPS
-
Certara Inc. (CERT) PT Raised to $27 at BofA Securities
-
Stephens Starts Certara Inc. (CERT) at Overweight
-
Barclays Downgrades Certara Inc. (CERT) to Equalweight
-
Certara Inc. (CERT) PT Raised to $27 at Credit Suisse
-
After-hours movers: Esperion sinks on Daiichi Sankyo dispute, Adobe gains on EPS
-
CVR Energy (CVI) to S&P SmallCap 600; Exponent (EXPO) to S&P MidCap 400
-
Certara Inc. (CERT) PT Raised to $21 at Morgan Stanley
-
Certara Inc. (CERT) PT Raised to $25 at Berenberg
-
Certara Inc. (CERT) PT Raised to $20 at Baird
-
Certara Inc. (CERT) PT Raised to $21 at Barclays
-
Certara Inc. (CERT) PT Raised to $22 at Credit Suisse
-
Certara, Inc. (CERT) Tops Q4 EPS by 3c; Offers Guidance
-
Certara, Inc. (CERT) Announces CFO Transition
-
Certara Inc. (CERT) PT Raised to $20 at Barclays
-
Certara, Inc. (CERT) Acquires Vyasa
-
Baird Downgrades Certara Inc. (CERT) to Neutral
-
Certara Inc. (CERT) PT Lowered to $20 at Credit Suisse
-
Certara Inc. (CERT) PT Lowered to $23 at BofA Securities
-
Certara Inc. (CERT) PT Lowered to $17 at Barclays
-
Berenberg has Greater Confidence in the Healthcare Sector (ABCL) (ABSI) (BLI) (RXRX) (RLAY) (CERT) (SDGR)
-
UPDATE: Berenberg Starts Certara Inc. (CERT) at Buy, Top Pick
-
Credit Suisse Starts Certara Inc. (CERT) at Outperform
Back to CERT Stock Lookup